sur LNA SANTE (EPA:LNA)
LNA Santé Reports Robust 2024 Growth Amid Regulatory Challenges
In 2024, LNA Santé registered a solid financial performance with operating revenue reaching €793.9 million, buoyed by the expansion in outpatient care services. The company reported proforma organic growth of 9.4% in Q4, showcasing strategic business alignment with healthcare trends.
Despite regulatory changes impacting medical and rehabilitation care, LNA Santé's comprehensive service offerings continue to meet patient needs across nursing homes, rehabilitation, mental health clinics, and home care services. In healthcare operations in France, sales surged by 14.2%, partly driven by higher volumes in outpatient and homecare services.
International business also witnessed growth, particularly in Belgian and Polish establishments. However, real estate sales faced a 22.5% decline, though signs of recovery emerged in Q4. Looking ahead, LNA Santé forecasts a 6.0% rise in 2025 operating sales, targeting nearly €845 million. The company remains committed to its mission, focusing on the "Growing Together 3" project.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de LNA SANTE